Flavivirus-induced antibody cross-reactivity.

Authors:
Address: Wildlife Zoonoses and Vector-borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, UK.
Journal:

Publication:

abstract

Dengue viruses (DENV) cause countless human deaths each year, whilst West Nile virus (WNV) has re-emerged as an important human pathogen. There are currently no WNV or DENV vaccines licensed for human use, yet vaccines exist against other Flaviviruses. To investigate flavivirus cross-reactivity, sera from a human cohort with a history of vaccination against tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV) and yellow fever virus (YFV) were tested for antibodies by plaque reduction neutralization test. Neutralization of louping ill virus (LIV) occurred, but no significant neutralization of Murray Valley encephalitis virus was observed. Sera from some individuals vaccinated against TBEV and JEV neutralized WNV, which was enhanced by YFV vaccination in some recipients. Similarly, some individuals neutralized DENV-2, but this was not significantly influenced by YFV vaccination. Antigenic cartography techniques were used to generate a geometric illustration of the neutralization titres of selected sera against WNV, TBEV, JEV, LIV, YFV and DENV-2. This demonstrated the individual variation in antibody responses. Most sera had detectable titres against LIV and some had titres against WNV and DENV-2. Generally, LIV titres were similar to titres against TBEV, confirming the close antigenic relationship between TBEV and LIV. JEV was also antigenically closer to TBEV than WNV, using these sera. The use of sera from individuals vaccinated against multiple pathogens is unique relative to previous applications of antigenic cartography techniques. It is evident from these data that notable differences exist between amino acid sequence identity and mapped antigenic relationships within the family Flaviviridae.

Related Articles
West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
Vector Borne Zoonotic Dis. 2005
West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR. Vector Borne Zoonotic Dis. 2005 Summer; 5(2):137-45.
Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
J Med Virol. 1985
Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
Kayser M, Klein H, Paasch I, Pilaski J, Blenk H, Heeg K. J Med Virol. 1985 Sep; 17(1):35-45.
[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
Mikrobiyol Bul. 2010
[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
Ergünay K, Saygan MB, Aydoğan S, Litzba N, Niedrig M, Pınar A, Us D. Mikrobiyol Bul. 2010 Jul; 44(3):415-24.
Review Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Vaccine. 2010
Review Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J. Vaccine. 2010 Jan 8; 28(3):632-49. Epub 2009 Oct 4.
Review Epitope mapping of flavivirus glycoproteins.
Adv Virus Res. 1986
Review Epitope mapping of flavivirus glycoproteins.
Heinz FX. Adv Virus Res. 1986; 31:103-68.
Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.
J Biomed Biotechnol. 2012
Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.
Hobson-Peters J. J Biomed Biotechnol. 2012; 2012:379738. Epub 2012 Apr 18.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.